Literature DB >> 1651937

Expression and analysis of Gs alpha mutants with decreased ability to activate adenylylcyclase.

H Itoh1, A G Gilman.   

Abstract

We have constructed mutants of the alpha subunit of Gs in an attempt to identify sites in the protein that are important for its interaction with adenylylcyclase. Some residues specific for those G proteins that activate adenylylcyclase were replaced with residues characteristic of Gi alpha. Mutant proteins were expressed in Escherichia coli, and two of these were purified to homogeneity and characterized in detail. Mutation of trp263, leu268, or arg269 caused a significant loss of the capacity of Gs alpha to stimulate adenylylcyclase, and the triple mutant had less than 1% of the ability of wild type Gs alpha to activate the enzyme. Guanine nucleotide binding and GTP hydrolysis by the mutant proteins were unaltered, as was guanosine 5'-3-O-(thio)triphosphate-induced enhancement of intrinsic tryptophan fluorescence. Mutant proteins also appeared to have a reduced affinity for the G protein beta gamma subunit complex. Secondary structure analysis and comparison with the structure of p21ras suggests that the region of Gs alpha that we have identified is part of a loop that may be involved in interaction of the protein with adenylylcyclase. Although these residues are essential for activation of adenylylcyclase, they are not sufficient to do this when placed in the context of another G protein alpha subunit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651937

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule.

Authors:  Akiyuki Nishimura; Ken Kitano; Jun Takasaki; Masatoshi Taniguchi; Norikazu Mizuno; Kenji Tago; Toshio Hakoshima; Hiroshi Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

2.  Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C.

Authors:  N J Pyne; M Freissmuth; S Palmer
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

3.  Gain-of-function screen of α-transducin identifies an essential phenylalanine residue necessary for full effector activation.

Authors:  Shawn K Milano; Chenyue Wang; Jon W Erickson; Richard A Cerione; Sekar Ramachandran
Journal:  J Biol Chem       Date:  2018-09-28       Impact factor: 5.157

Review 4.  Why there is no gene for alcoholism.

Authors:  E J Devor
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

5.  G-protein alpha o subunit: mutation of conserved cysteines identifies a subunit contact surface and alters GDP affinity.

Authors:  T C Thomas; C J Schmidt; E J Neer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

6.  Modulation of rat cardiac sodium channel by the stimulatory G protein alpha subunit.

Authors:  T Lu; H C Lee; J A Kabat; E F Shibata
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

7.  Ric-8B is a GTP-dependent G protein alphas guanine nucleotide exchange factor.

Authors:  PuiYee Chan; Meital Gabay; Forrest A Wright; Gregory G Tall
Journal:  J Biol Chem       Date:  2011-04-05       Impact factor: 5.157

8.  Persistent activation of Gsalpha through limited proteolysis by calpain.

Authors:  K Sato-Kusubata; Y Yajima; S Kawashima
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

9.  Ric-8B stabilizes the alpha subunit of stimulatory G protein by inhibiting its ubiquitination.

Authors:  Yusuke Nagai; Akiyuki Nishimura; Kenji Tago; Norikazu Mizuno; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2010-02-04       Impact factor: 5.157

10.  Requirement for posttranslational processing of Rac GTP-binding proteins for activation of human neutrophil NADPH oxidase.

Authors:  P G Heyworth; U G Knaus; X Xu; D J Uhlinger; L Conroy; G M Bokoch; J T Curnutte
Journal:  Mol Biol Cell       Date:  1993-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.